Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Peripher Nerv Syst. 2013 Sep;18(3):209–219. doi: 10.1111/jns5.12033

Table 1. Summary of insulin dose curve insulin signaling pathway activation in the DRG and sciatic nerve.

Analyzed results of in vivo insulin signaling in the DRG and sciatic nerve in response to an insulin dose curve indicate that both sensory neuron cell bodies and the peripheral nerve are insulin responsive. Interestingly, differences in downstream signaling may exist between the DRG and sciatic nerve. Data was fit with a sigmoidal dose response curve and analyzed with a 1-way ANOVA and Dunnett’s post hoc. “not converged” indicates that the sigmoidal dose response curve equation was unable to fit the data.

Protein of Interest Dose Curve EC50 Dose Curve R2value 10000U/kg Insulin-induced fold
change as compared to baseline
DRG Sciatic Nerve DRG Sciatic Nerve DRG Sciatic Nerve
Akt (t308) 33.05 16.3 0.71 0.76 13.9*** 18.1***
Akt(s473) 131.3 232.1 0.88 0.63 9.2*** 30.5*
GSK3β (s9) not converged 18367.0 not converted 0.62 1.2 2.9***
AS160(t642) 26.4 4.1 0.33 0.43 1.7* 3.0**
mTor (s2448) 39.8 ~11.3 0.28 0.34 1.4* 1.6
ERK (Thr202/Tyr204) not converted 5682.0 not converted 0.24 2.1*** 1.8*
*

=p<0.05,

**

=p<0.01,

***

=p<0.001.